B4Y-15240-25375
3 vaccinations
3 coded responses
37 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-04-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-18
Registered in v-safe
-
2021-04-18
Dose 1 — Moderna
-
2021-04-18
Survey response — day 0, dose 1MedDRA: Injection site bruising, Injection site pain — Feeling: GoodFree text: Bruise and tenderness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-05-02
- 2021-05-09
-
2021-05-16
Dose 2 — Moderna
- 2021-05-16
-
2021-05-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-18
-
2021-05-19
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia, Vision blurred — Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesFree text: Numbness and tingling in hands and occasionally blurry visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-20
- 2021-05-21
- 2021-05-22
- 2021-05-23
- 2021-05-30
-
2021-06-08
Survey response — day 21, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: Menstrual cycle changesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-13
- 2021-06-20
- 2021-06-27
- 2021-08-15
- 2021-11-14
-
2022-01-08
Dose 3 — Moderna
-
2022-01-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-11
- 2022-01-12
- 2022-01-14
- 2022-01-15
- 2022-01-22
- 2022-01-29
- 2022-02-05
- 2022-02-14
- 2022-02-21
- 2022-04-09
- 2022-07-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-18 | Moderna | |
| 2 | 2021-05-16 | Moderna | |
| 3 | 2022-01-08 | Moderna | No |
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Bruise and tenderness at injection site
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Numbness and tingling in hands and occasionally blurry vision
Release 8 — day 21, dose 2
Symptoms: Menstrual cycle changes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release